ArticleMolecular biology reports2026
Insulin pathway components and insulin effects on rho kinase in rat colon.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe RhoA/Rho-associated protein kinase (ROCK) signaling pathway plays a central role in regulating smooth muscle contraction by inhibiting myosin light chain phosphatase. While insulin has been shown to modulate ROCK activity in vascular and airway smooth muscle, its effects on gastrointestinal (GI) smooth muscle remain largely unexplored. Insulin exerts its effects through a cascade involving the insulin receptor (IR), insulin receptor substrates (IRS), phosphoinositide 3-kinase (PI3K) subunits such as p110, and downstream effectors including ROCK. The aim of the current study was to characterize the expression profile of key insulin signaling components, including IR, IRS isoforms (IRS1/2), PI3K catalytic subunits (p110α/β), and ROCK isoforms (ROCK1/2), in normal rat colon, and to determine whether insulin affects ROCK activity. METHODS AND
resultsAdult Sprague-Dawley rats were used to obtain colonic tissue samples. Immunohistochemistry (IHC) was performed to localize IR protein expression. Quantitative PCR was used to evaluate the mRNA expression levels of IRA/B, IRS1/2, p110α/β, and ROCK1/2. The effect of insulin on acetylcholine-induced activation of ROCK was measured using a specifically designed activity assay kit. IHC confirmed the expression of IR protein in both mucosal and muscle layers of the colon wall tissue. Messenger RNA expression levels of IRA, IRS2, p110α, and ROCK2 isoforms were greater than IRB, IRS1, p110β, and ROCK1 isoforms respectively. Insulin significantly reduced acetylcholine-induced activation of ROCK.
conclusionthe results suggest that the colon is responsive to insulin and exhibits a distinct insulin signaling pattern. Insulin may modulate colonic contractile signaling through ROCK activity.
Indexed as
Identifiers
42525159What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.